California State Teachers Retirement System (CalSTRS)’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.1K Sell
1,378
-190
-12% -$2.85K ﹤0.01% 2475
2025
Q4
$24.2K Buy
1,568
+67
+4% +$896 ﹤0.01% 2452
2025
Q3
$15.5K Buy
1,501
+1
+0.1% +$9 ﹤0.01% 2652
2025
Q2
$16.7K Buy
1,500
+511
+52% +$6.39K ﹤0.01% 2550
2025
Q1
$12.2K Hold
989
﹤0.01% 2705
2024
Q4
$11.1K Hold
989
﹤0.01% 2826
2024
Q3
$6.89K Hold
989
﹤0.01% 2965
2024
Q2
$7.48K Buy
+989
New +$9.98K ﹤0.01% 2983
2022
Q2
Sell
-3,025
Closed -$25K 3251
2022
Q1
$25K Sell
3,025
-468
-13% -$4.04K ﹤0.01% 3156
2021
Q4
$35K Sell
3,493
-228
-6% -$2.96K ﹤0.01% 3205
2021
Q3
$59K Sell
3,721
-5,866
-61% -$123K ﹤0.01% 3097
2021
Q2
$228K Buy
+9,587
New +$223K ﹤0.01% 2973

Other funds holding NPCE

California State Teachers Retirement System (CalSTRS)'s NPCE Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Neuropace (NPCE) stake by 12% in Q1 2026, selling an estimated $2.85K and leaving 1,378 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

California State Teachers Retirement System (CalSTRS) first reported a position in NPCE in Q2 2021 and has held it in 12 quarters since. The position peaked at $228K in Q2 2021. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 1,378 shares of Neuropace worth $18.1K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 190 Neuropace shares in Q1 2026, an estimated $2.85K.
  • Neuropace made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2475 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Neuropace in Q2 2021 and has held it in 12 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Neuropace position peaked at $228K in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.